ClinicalTrials.gov
ClinicalTrials.gov Menu

Effects of Isolated Rooms on the Prevalence of Hospital Acquired Pneumonia in a Respiratory ICU

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01250691
Recruitment Status : Completed
First Posted : December 1, 2010
Last Update Posted : December 1, 2010
Sponsor:
Information provided by:
Eskisehir Osmangazi University

Brief Summary:
This study will carry out in the ICU. Objectives of the study are to determine the frequency of HAP and the effect of isolated rooms on the frequency of pneumonia in the ICU.

Condition or disease Intervention/treatment
Pneumonia Intensive Care Unit Other: ward-type ICU

Detailed Description:
In the present study, it was aimed to determine the incidence, causative agents, antimicrobial resistance, and risk factors for lower respiratory tract infections in patients followed in the ICU for the last 4 years. The effect of reconfiguration from a ward-type ICU consisting one large room to an ICU with isolated rooms with two beds on the incidence of HAP was also determined.

Study Type : Observational
Actual Enrollment : 532 participants
Observational Model: Cohort
Time Perspective: Cross-Sectional
Official Title: Epidemiologic Study of Hospital Acquired Pneumonia in a Respiratory ICU
Study Start Date : January 2004
Actual Primary Completion Date : July 2008
Actual Study Completion Date : August 2010

Resource links provided by the National Library of Medicine

U.S. FDA Resources

Group/Cohort Intervention/treatment
hospital acquired pneumonia
isolated rooms Other: ward-type ICU
frequency of hospital acquired pneumonia in the ICU
Other Name: frequency of hospital acquired pneumonia in the ICU
ward-type ICU




Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
All of the patients who had been admitted to the ICU during this period were included in the study
Criteria

Inclusion Criteria:

  • adult patients,
  • admitted to the ICU

Exclusion Criteria:

  • trauma, surgery or burned patients
  • patients under 18

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01250691


Locations
Turkey
Eskisehir Osmangazi University
Eskisehir, Merkez, Turkey, 26040
Osmangazi University
Eskisehir, Merkez, Turkey, 26040
Eskisehir Osmangazi University
Eskisehir, Turkey, 26040
Sponsors and Collaborators
Eskisehir Osmangazi University
Investigators
Study Chair: Irfan Ucgun, As.Prof.Dr. Eskisehir Osmangazi University, Medical Faculty

Responsible Party: Eskisehir Osmangazi University, Department of Chest Diseases, Intensive Care Unit, Eskisehir Osmangazi University
ClinicalTrials.gov Identifier: NCT01250691     History of Changes
Other Study ID Numbers: HAP-OU-isolation
First Posted: December 1, 2010    Key Record Dates
Last Update Posted: December 1, 2010
Last Verified: January 2004

Keywords provided by Eskisehir Osmangazi University:
pneumonia
ICU
isolation room
clinical epidemiology
infection control

Additional relevant MeSH terms:
Pneumonia
Lung Diseases
Respiratory Tract Diseases
Respiratory Tract Infections